# Testosterone and Neural Function

> **NCT06130449** · EARLY_PHASE1 · RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 15 (estimated)

## Conditions studied

- Spinal Cord Injury

## Interventions

- **DRUG:** Natesto testosterone intranasal gel
- **DRUG:** Ayr Saline Nasal Gel

## Key facts

- **NCT ID:** NCT06130449
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06130449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06130449, "Testosterone and Neural Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06130449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*